CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-01 | COZADD BRUCE C Chairman & CEO | Option exercise | +9,700 | $46.83 | $454K | 332,160 |
| 2022-02-01 | COZADD BRUCE C Chairman & CEO | Sale | −2,050 | $138.11 | $283K | 330,110 |
| 2022-02-01 | COZADD BRUCE C Chairman & CEO | Sale | −2,136 | $139.24 | $297K | 327,974 |
| 2022-02-01 | COZADD BRUCE C Chairman & CEO | Sale | −2,186 | $140.26 | $307K | 325,788 |
| 2022-02-01 | COZADD BRUCE C Chairman & CEO | Option exercise · Non-Qualified Stock Option (right to buy) | −9,700 | 58,132 | ||
| 2022-01-03 | Swisher Daniel N JR President and COO | Shares withheld for taxes | −1,624 | $131.01 | $213K | 48,546 |
| 2022-01-03 | COZADD BRUCE C Chairman & CEO | Option exercise | +9,700 | $46.83 | $454K | 328,251 |
| 2022-01-03 | COZADD BRUCE C Chairman & CEO | Sale | −1,819 | $126.72 | $231K | 326,432 |
| 2022-01-03 | COZADD BRUCE C Chairman & CEO | Sale | −1,181 | $127.58 | $151K | 325,251 |
| 2022-01-03 | COZADD BRUCE C Chairman & CEO | Sale | −2,651 | $128.67 | $341K | 322,600 |
| 2022-01-03 | COZADD BRUCE C Chairman & CEO | Sale | −140 | $129.34 | $18K | 322,460 |
| 2022-01-03 | COZADD BRUCE C Chairman & CEO | Option exercise · Non-Qualified Stock Option (right to buy) | −9,700 | 67,832 | ||
| 2021-12-02 | Smith Mark Douglas Director | Sale | −417 | $121.30 | $51K | 4,419 |
| 2021-12-02 | Cook Jennifer E. Director | Sale | −417 | $121.30 | $51K | 4,419 |
| 2021-12-01 | COZADD BRUCE C Chairman & CEO | Option exercise | +9,700 | $46.83 | $454K | 325,299 |
| 2021-12-01 | COZADD BRUCE C Chairman & CEO | Sale | −3,990 | $122.38 | $488K | 321,309 |
| 2021-12-01 | COZADD BRUCE C Chairman & CEO | Sale | −2,758 | $123.06 | $339K | 318,551 |
| 2021-12-01 | COZADD BRUCE C Chairman & CEO | Option exercise · Non-Qualified Stock Option (right to buy) | −9,700 | 77,532 | ||
| 2021-11-12 | Larkin Finbar SVP, Technical Operations | Sale | −197 | $135.79 | $27K | 16,468 |
| 2021-11-11 | Sablich Kim EVP & GM, North America | Sale | −2,748 | $135.01 | $371K | 21,135 |
Page 30 of 31 · 614 trades